Access the full text.
Sign up today, get DeepDyve free for 14 days.
KH Stauder (1934)
Die todliche KatatoniaArch Psychiatr Nervenkr, 102
JM Davis, SN Caroff, SC Mann (2000)
Treatment of neuroleptic malignant syndromePsychiatr Ann, 30
SC Mann, SN Caroff, HR Bleier, WKR Welz, MA Kling, M Hayashida (1986)
Lethal catatoniaAm J Psychiatr, 143
AY Deutch, AJ Bourdelais, DS Zahm (1993)
Limbic motor circuits and neuropsychiatry
G Fricchione, G Bush, M Fozdar, A Francis, M Fink (1997)
Recognition and treatment of the catatonic syndromeJ Intensive Care Med, 12
SC Mann (2003)
Neuroleptic malignant syndrome and related conditions
A Stoudemire, JS Luther (1984)
Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatmentInt J Psychiatr Med, 14
SN Caroff, SC Mann (1988)
Neuroleptic malignant syndromePsychopharmacol Bull, 24
DE Huddleston, SA Factor (2013)
Movement disorder emergencies: diagnosis and treatment
JWY Lee (2004)
Catatonia: from psychopathology to neurobiology
AJ Gelenberg, MR Mandel (1977)
Catatonic reactions to high-potency neuroleptic drugsArch Gen Psychiatr, 34
GL Fricchione (1985)
Neuroleptic catatonia and its relationship to psychogenic catatoniaBiol Psychiatr, 20
Psychopharmacology (2015) 232:661–662 DOI 10.1007/s00213-015-3864-7 LETTER TO THE EDITOR Stanley N. Caroff & Stephan C. Mann & E. Cabrina Campbell Received: 28 December 2014 /Accepted: 1 January 2015 /Published online: 16 January 2015 Springer-Verlag Berlin Heidelberg (outside the USA) 2015 To the editor; drug cessation provides a resolution of the catatonic dilemma In their scholarly analysis of published reports of neuroleptic and an “external validation” of the diagnosis of NMS, albeit malignant syndrome (NMS) and catatonia, Lang et al. (2014) post hoc. However, if symptoms of NMS do not resolve after found 12 variables with statistically significant discriminatory drug discontinuation, evidence has also been published sug- power in differentiating the 2 disorders. Given the seriousness gesting several drug treatments, including lorazepam, and of these disorders, the infrequency of their occurrence, and the ECT may improve recovery (Davis et al. 2000). general lack of research data and awareness among clinicians, Second, it is not surprising that Lang et al. found that symp- the analysis by Lang et al. to differentiate NMS from catatonia toms of parkinsonism (rigidity and tremor) are more common is an important endeavor. However, there are three points we in NMS than in cases of catatonia. In
Psychopharmacology – Springer Journals
Published: Feb 1, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.